Ong is the vice president of Maybank Securities and has been since 2007. He is also the non-executive chairman and lead independent director of Catalist-listed VCPlus. In addition, Ong is a director of a consultancy company providing business and management advisory services. According to Clearbridge’s filing on Dec 19, 2024, Ong has 17 years of experience with corporate finance transactions and fund-raising including initial public offerings and reverse take-overs. He was first introduced to Clearbridge by the senior management of the company.
Clearbridge Health has completed the proposed placement of 309.5 million new ordinary shares to its subscriber, Ong Choon Yi, on Jan 10.
The company entered into a subscription agreement with Ong on Dec 19, 2024, where Ong agreed to subscribe and pay $959,450 for the shares. The price translates to 0.31 cents per share, which is equivalent to the volume weighted average price (VWAP) of 0.31 cents per ordinary share in the capital of the company based on trades done on the same day.
